- Home
- FY22 expansion plans
FY22 expansion plans
1 post
Recent Posts
- Novel Anti-Fibrotic Drug AK3280 Cleared by FDA to Initiate Phase 2 Proof-of-Concept Clinical Trial in IPF February 12, 2026
- Quarterly Earnings Release I Q3 FY2025-26 1Point1 Solutions Reports Strong Financial Performance in Q3FY26 February 12, 2026
- Xpheno appoints Pallavi Nanduru as Hyderabad Center Head to drive Executive Search growth in India’s fast-growing GCC ecosystem February 12, 2026
- Inntot Technologies Crosses Two Million Software-Defined Radio Deployments, Marking Rapid Growth in Automotive Digital Radio February 12, 2026
- TOKYO CREATIVE SALON 2026 Program Highlights City-Wide Creativity Across Tokyo February 12, 2026

